Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13,275 JPY | -0.71% | -5.82% | -18.48% |
Apr. 12 | Cosmos Pharmaceutical's Attributable Profit Up 6.6% in Fiscal Nine Months | MT |
Apr. 12 | COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.48% | 3.39B | |
-12.75% | 2.95B | |
-26.96% | 2.93B | |
+13.45% | 2.74B | |
+10.43% | 2.79B | |
-2.28% | 1.9B | |
+10.93% | 1.39B | |
-19.89% | 976M | |
-0.53% | 465M | |
+5.58% | 400M |
- Stock Market
- Equities
- 3349 Stock
- News COSMOS Pharmaceutical Corporation
- UBS Adjusts Cosmos Pharmaceutical's Price Target to 16,500 Yen From 17,500 Yen, Keeps at Neutral